Nation

Pfizer developing vaccine to target omicron; unvaccinated make up most of NY breakthrough infections: COVID-19 updates

Pfizer's CEO Albert Bourla said developing a COVID vaccine specifically designed to target omicron is "the most likely scenario." Latest news.